HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced that an overview of the Company’s business strategy and commercial and development-stage programs will be given at the Oppenheimer 23rd Annual Healthcare Conference being held at the Waldorf=Astoria in New York City. The Company presentation is on Wednesday, December 12, 2012, at 10:35 AM ET.
